These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21392062)

  • 1. Maximizing efficiency and cost-effectiveness of Type 2 diabetes screening: the AusDiab study.
    Chen L; Magliano DJ; Balkau B; Wolfe R; Brown L; Tonkin AM; Zimmet PZ; Shaw JE
    Diabet Med; 2011 Apr; 28(4):414-23. PubMed ID: 21392062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can a screening programme for diabetes be applied to another population?
    Glümer C; Borch-Johnsen K; Colagiuri S
    Diabet Med; 2005 Sep; 22(9):1234-8. PubMed ID: 16108854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for diabetes.
    Backholer K; Chen L; Shaw J
    Pathology; 2012 Feb; 44(2):110-4. PubMed ID: 22228253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of type 2 diabetes screening: results from recently published studies.
    Icks A; Rathmann W; Haastert B; John J; Löwel H; Holle R; Giani G;
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S167-71. PubMed ID: 16032536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using an economic model of diabetes to evaluate prevention and care strategies in Australia.
    Colagiuri S; Walker AE
    Health Aff (Millwood); 2008; 27(1):256-68. PubMed ID: 18180502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study.
    Davis WA; Knuiman MW; Hendrie D; Davis TM
    Intern Med J; 2006 Mar; 36(3):155-61. PubMed ID: 16503950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of coronary artery disease screening in asymptomatic patients with type 2 diabetes and other atherogenic risk factors in Japan: factors influencing on international application of evidence-based guidelines.
    Hayashino Y; Shimbo T; Tsujii S; Ishii H; Kondo H; Nakamura T; Nagata-Kobayashi S; Fukui T
    Int J Cardiol; 2007 May; 118(1):88-96. PubMed ID: 16949690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacy diabetes care program: analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy.
    Krass I; Mitchell B; Clarke P; Brillant M; Dienaar R; Hughes J; Lau P; Peterson G; Stewart K; Taylor S; Wilkinson J; Armour C
    Diabetes Res Clin Pract; 2007 Mar; 75(3):339-47. PubMed ID: 16884811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple clinical score for type 2 diabetes mellitus screening in the Canary Islands.
    Cabrera de León A; Coello SD; Rodríguez Pérez Mdel C; Medina MB; Almeida González D; Díaz BB; de Fuentes MM; Aguirre-Jaime A
    Diabetes Res Clin Pract; 2008 Apr; 80(1):128-33. PubMed ID: 18082285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost of screening for diabetes and intermediate hyperglycaemia.
    Colagiuri S
    Diabetes Res Clin Pract; 2012 Sep; 97(3):341-2. PubMed ID: 22682947
    [No Abstract]   [Full Text] [Related]  

  • 11. [Screening and intervention. A strategy in type 2 diabetes?].
    Jørgensen T; Glümer C; Borch-Johnsen K
    Ugeskr Laeger; 2002 Apr; 164(16):2135-9. PubMed ID: 11989055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding undiagnosed type 2 diabetes: is it worth the effort?
    Engelgau MM; Narayan KM
    Eff Clin Pract; 2001; 4(6):281-3. PubMed ID: 11769302
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for type 2 diabetes in the Iranian national programme: a preliminary report.
    Azizi F; Guoya MM; Vazirian P; Dolatshati P; Habbibian S
    East Mediterr Health J; 2003; 9(5-6):1122-7. PubMed ID: 16450546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a population-based screening for type 2 diabetes: a community-based screening project in Puli, Taiwan.
    Chang HJ; Kuo HS; Tung TH; Chou P; Chen TH
    Prev Med; 2000 Oct; 31(4):396-402. PubMed ID: 11006065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of screening of all newly recruited employees for diabetes at a tertiary care hospital.
    Ali NS; Khuwaja AK
    J Ayub Med Coll Abbottabad; 2007; 19(2):23-5. PubMed ID: 18183713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of risk factors scoring method in screening for undiagnosed diabetes in general population].
    Shen H; Yu S; Xu Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Apr; 20(2):114-7. PubMed ID: 10682548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).
    Hauner H; Hanisch J; Bramlage P; Steinhagen-Thiessen E; Schunkert H; Jöckel KH; Wasem J; Moebus S
    Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):18-25. PubMed ID: 17926235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socioeconomic factors related to attendance at a Type 2 diabetes screening programme.
    Dalsgaard EM; Lauritzen T; Christiansen T; Mai KS; Borch-Johnsen K; Sandbaek A
    Diabet Med; 2009 May; 26(5):518-25. PubMed ID: 19646192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness.
    Holt RI; Abdelrahman T; Hirsch M; Dhesi Z; George T; Blincoe T; Peveler RC
    J Psychopharmacol; 2010 Jun; 24(6):867-73. PubMed ID: 19304868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the prevalence of diabetes risk-factors among First Nation, Métis and non-Aboriginal adults attending screening clinics in rural Alberta, Canada.
    Oster RT; Toth EL
    Rural Remote Health; 2009; 9(2):1170. PubMed ID: 19496641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.